Try Mental Wellness – Lifestyle
Author:
PatentVest, Inc.
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
May 8, 2026
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
April 29, 2026
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
March 31, 2026
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
March 30, 2026
PatentVest Announces Life Seal Vascular Partnership, Takes Equity Stake in Exchange for IP Intelligence Services
March 30, 2026
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
March 11, 2026